NKT Therapeutics, Inc.

Newton, Massachusetts-based Siamab Therapeutics, a biotechnology company developing cancer immunotherapies, has appointed Dr Robert Mashal, current president and chief executive officer of NKT Therape

The standard of care in sickle cell anemia is treatment of pain during vaso-occlusive crisis (VOC) that occurs when sickled cells adhere and block the flow of blood and oxygen, but there are a handful

Corporate venture funds are taking an increasingly high-profile role in biotech financing deals. Eva Jack and Dr Maggie Flanagan LeFlore, managing directors of MedImmune Ventures, explain to Pete Chan

A preview of the emerging health care companies profiled in the current issue of START-UP: Windhover’s Review of Emerging Medical Ventures This month's profile group: Start-Ups Set Sights on Flu Ali